Saturday, October 29, 2016: 2:00 PM-3:30 PM
Room: Theater A & B

At the conclusion of this session, participants will be able to:
- improve their skills in case-based infectious disease
- better evaluate unusual infections or mimics of infections








H. Chambers,
Allergan:
Scientific Advisor
,
Consulting fee
The Medicines Company:
Grant Investigator
,
Research grant
Genentech:
Grant Investigator
and
Scientific Advisor
,
Consulting fee
and
Research grant
L. G. Winston, None
D. P. Kontoyiannis, Merck: Scientific Advisor and Speaker's Bureau , Consulting fee and Speaker honorarium
Astellas: Investigator and Speaker's Bureau , Research grant and Speaker honorarium
Cidara: Consultant , Consulting fee
Amplyx: Consultant , Consulting fee
F2G: Consultant , Consulting fee
R. Read, Glaxo Smith Kline: Grant Investigator , Research support
See more of: Interactive Session